Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
16.48
-0.74 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
16.50
+0.02 (0.12%)
After-hours: Nov 20, 2026, 7:31 PM EST
Ultragenyx Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $35 → $24 | Buy | Reiterates | $35 → $24 | +45.63% | Nov 17, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $22 | Hold | Maintains | $22 | +33.50% | Nov 16, 2026 |
| Citi | Citi | Buy Maintains $32 → $22 | Buy | Maintains | $32 → $22 | +33.50% | Nov 5, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $33 | Buy | Reiterates | $33 | +100.24% | Nov 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $36 | Buy | Maintains | $36 | +118.45% | Nov 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +51.70% | Nov 5, 2026 |
| Barclays | Barclays | Buy Maintains $35 → $32 | Buy | Maintains | $35 → $32 | +94.17% | Nov 5, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $39 | Buy | Maintains | $39 | +136.65% | Nov 4, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.